06.02.2023 - WARMINSTER, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) - Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral ...

Related Keywords

Lisam Caperelli , Williamh Collier , , Arbutus Biopharma Corporation Nasdaq , Health Care Conference , Annual Health Care Conference , Formal Presentation , Bay Summit , Biopharma Corporation ,